Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Twist Bioscience Corporation

< Previous 1 2 3 4 5 Next >
Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Expands Express Genes Rapid Synthesis Service
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Appoints Adam Laponis as Chief Financial Officer
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2023 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Launches Express Genes Rapid Gene Synthesis Service
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at 6th Annual Evercore ISI HealthCONx Conference
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Report Fiscal 2023 Fourth Quarter and Full Year Financial Results on Friday, November 17, 2023
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Launches Full Length Unique Dual Index Adapters to Enable PCR-free Whole Genome Sequencing
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Appoints Mark Buck as Senior Vice President, Operations
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience and IMIDomics Collaborate to Discover Antibodies for Applications in Immune-Mediated Inflammatory Diseases
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at Upcoming Investor Conferences
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Releases 2023 ESG Report and Quantifies Carbon Footprint of Manufacturing a Single Gene
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at the UBS MedTech, Tools and Genomics Summit 2023
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Reports Fiscal Third Quarter 2023 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Report Fiscal 2023 Third Quarter Financial Results on Friday, August 4, 2023
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience and Cancer Research Horizons Enter into Collaboration to Advance Cancer Research
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Publishes Preclinical Data in Diabetes Validating GLP-1R Antagonist Antibody as Potential Treatment for Congenital Hyperinsulinism
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Appoints Chet Gandhi as Chief Information Officer
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience and CeGaT Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience to Present at Upcoming Investor Conferences
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
Twist Bioscience Appoints Robert Werner as Chief Accounting Officer
From Twist Bioscience Corporation
Via Business Wire
Tickers TWST
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.